Nuvation Bio Inc.
NUVB
$2.18
$0.020.93%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -49.45M | -41.21M | -462.49M | -14.79M | -13.79M |
| Total Depreciation and Amortization | 219.00K | 162.00K | 244.00K | 58.00K | 55.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.67M | 4.99M | 431.05M | 3.64M | 144.00K |
| Change in Net Operating Assets | -6.75M | 4.97M | -6.13M | -4.61M | -1.44M |
| Cash from Operations | -46.30M | -31.09M | -37.32M | -15.70M | -15.03M |
| Capital Expenditure | 13.00K | -148.00K | 0.00 | -27.00K | -13.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 14.00K |
| Cash Acquisitions | -92.00K | 0.00 | 12.52M | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 51.85M | 29.26M | 21.75M | 7.57M | 33.16M |
| Cash from Investing | 51.77M | 29.12M | 34.27M | 7.54M | 33.16M |
| Total Debt Issued | 5.57M | 0.00 | 7.04M | -- | -- |
| Total Debt Repaid | -7.63M | -3.21M | -6.32M | -- | -- |
| Issuance of Common Stock | 1.16M | 1.67M | 2.04M | 21.00K | 120.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -900.00K | -1.54M | 2.75M | 21.00K | 120.00K |
| Foreign Exchange rate Adjustments | 1.12M | -742.00K | 78.00K | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.69M | -4.25M | -225.00K | -8.14M | 18.25M |